Skip to main content
SpringerLink
Log in

TZDs linked to adverse CV outcomes in older DM patients

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Lipscombe LL, Gomes T, Lévesque LE, Hux JE, Juurlink DN, Alter DA.Thiazolidinediones and cardiovascular outcomes in older patients with diabetes. JAMA: the Journal of the American Medical Association 298: 2634-2643, No. 22, 12 Dec 2007

  2. Institute for Clinical Evaluative Sciences.More evidence suggests diabetes drug may be dangerous. Media Release: 11 Dec 2007. Available from: URL: http://www.ices.on.ca

  3. GlaxoSmithKline.GlaxoSmithKline Responds to JAMA Article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes. Media Release: 11 Dec 2007. Available from: URL: http://www.gsk.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

TZDs linked to adverse CV outcomes in older DM patients. React. Wkly. 1183, 3 (2008). https://doi.org/10.2165/00128415-200811830-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200811830-00007

Keywords

Search

Navigation